Press room
  • Products
  • Science
  • About
  • Investor Relations
  • Products
    • Animal HealthNutraceuticalsWebinars
  • Science
    • Our SciencePatentsScientific Reports
  • About
    • About AxichemMissionVisionJoin UsEco-friendlyHistoryBusiness model
  • Investor Relations
    • Commissioned ResearchCompany descriptionCorporate GovernanceFinancial CalendarFinancial ReportsGeneral Meetings ArchiveInvestor EnquiriesInvestor structurePress ReleasesProspectus ArchiveAnnual General Meeting 2026
axichem.se Press releases
Inbjudan att teckna aktier i aXichem AB
Back
October 14, 2009
Inbjudan att teckna aktier i aXichem AB
Back

  • Härmed inbjuds allmänheten att teckna aktier i aXichem AB
  • 4,50 SEK aktie
Back
Further reading
September 08, 2026
aXichem notes growing commercial adoption in Brazil for aXiphen[®] ruminant as Garra Nutrição increases volume to four tonnes
September 08, 2026
aXichem ser växande kommersiell användning i Brasilien för aXiphen[® ]ruminant då Garra Nutrição ökar volymen till fyra ton
September 04, 2026
aXichem meddelar teckningskurs för TO2A, som kan nyttjas under perioden 7 – 18 september 2026
Our Brands
aXiphen
Animal Health - read more
aXivite
Nutraceuticals and life-science - read more
back to top
 
Södergatan 26
211 34 Malmö
SWEDEN
+46 40 12 13 55

 
About
Science and R&D
Products
Investor Relations
Press Room
Join Us
Contact
Sitemap

© aXichem AB 2024